Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

ClinicalTrials.gov ID: NCT01363011

Public ClinicalTrials.gov record NCT01363011. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is to characterize the effect of cobicistat-based regimens on parameters of renal function in participants with HIV infection and who have mild to moderate renal impairment, and to assess the safety and tolerability of the regimens in order to generate appropriate dosing recommendations.

Study identification

NCT ID
NCT01363011
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
106 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2011
Primary completion
Dec 31, 2012
Completion
Jan 31, 2015
Last update posted
May 1, 2016

2011 – 2015

United States locations

U.S. sites
34
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Spectrum Medical Group Phoenix Arizona 85012
Health for Life Clinic Little Rock Arkansas 72207
AHF Research Center Beverly Hills California 90211
Kaiser Permanente Los Angeles California 90027
Peter J. Ruane, M.D., Inc. Los Angeles California 90036
Anthony Mills, MD, Inc. Los Angeles California 90069
Orange Coast Medical Group Newport Beach California 92663
East Bay AIDS Center Oakland California 94609
University of California, Davis Sacramento California 01105
Metropolis Medical San Francisco California 94115
National Jewish Health Denver Colorado 80206
Yale University School of Medicine AIDS Program New Haven Connecticut 06520
Whitman Walker Clinic Washington D.C. District of Columbia 20009
Medical Faculty Associates Washington D.C. District of Columbia 20037
Therafirst Medical Center Fort Lauderdale Florida 33308
Broward Health Fort Lauderdale Florida 33311
Gary J. Richmond.M.D.,P.A. Fort Lauderdale Florida 33316
Midway Immunology and Research Center Ft. Pierce Florida 34982
Orlando Immunology Center Orlando Florida 32803
IDOCF/ValueHealthMD, LLC Orlando Florida 32806
Infectious Disease Specialists of Atlanta Decatur Georgia 30033
Mercer University/ Mercer Medicine Clinical Research Macon Georgia 31201
Northstar Medical Center Chicago Illinois 60657
The Research Institute Springfield Massachusetts 01105
Central West Clinical Research, Inc. St Louis Missouri 63108
ID Care Hillsborough New Jersey 08844
North Shore University Hospital Manhasset New York 11030
Chelsea Village Medical New York New York 10011
Mount Sinai Downtown Comprehensive Health Program New York New York 10011
AIDS Care Rochester New York 14607
Carolinas Medical Center Charlotte North Carolina 28207
Southwest Infectious Disease Clinical Research, Inc. Addison Texas 75001
Tarrant County Infectious Disease Associates Fort Worth Texas 76104
Therapeutic Concepts, PA Houston Texas 77004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01363011, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2016 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01363011 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →